Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.

MLA

Khan, Tashbib, et al. “Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.” Cancers, vol. 12, no. 4, Apr. 2020. EBSCOhost, https://doi.org/10.3390/cancers12040869.

APA

Khan, T., He, Y., Kryza, T., Harrington, B. S., Gunter, J. H., Sullivan, M. A., Cuda, T., Rogers, R., Davies, C. M., Broomfield, A., Gough, M., Wu, A. C., McGann, T., Weroha, S. J., Haluska, P., Forbes, J. M., Armes, J. E., Barry, S. C., Coward, J. I., … Hooper, J. D. (2020). Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma. Cancers, 12(4). https://doi.org/10.3390/cancers12040869

Chicago

Khan, Tashbib, Yaowu He, Thomas Kryza, Brittney S Harrington, Jennifer H Gunter, Mitchell A Sullivan, Tahleesa Cuda, et al. 2020. “Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.” Cancers 12 (4). doi:10.3390/cancers12040869.